Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03512262 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM)
A Phase 3 study, sponsored by Radius Health.
- Completed
- Registry status
- Phase 3
- Development phase
- 228
- Enrollment target
NCT03512262: Completed Phase 3 study, sponsored by Radius Health.
NCT03512262 is a Phase 3 study that has completed, run by Radius Health. The registered enrollment target is 228 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03512262, a Phase 3 study, has completed, sponsored by Radius Health.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 228 participants
- Enrollment target
Study Summary
A 12-month study to measure the efficacy and safety of abaloparatide in men with osteoporosis.
Primary Outcome
Lumbar Spine BMD was assessed by DXA scans evaluated by a central imaging laboratory. Lumbar spine scans included L1 through L4. Positive changes from baseline indicate improvement in bone health.
Interventions
- DRUG Placebo
- DRUG Abaloparatide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 228 participants |
| Start Date | 2018-05-03 |
| Est. Completion | 2021-09-08 |
| Phase | Phase 3 |
What the finished NCT03512262 record still lists
NCT03512262 is an interventional study that assigns participants to a tested intervention. The registered 228 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (70% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03512262 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03512262 about?
NCT03512262 is a clinical study titled "Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM)". A 12-month study to measure the efficacy and safety of abaloparatide in men with osteoporosis.
What is the current status of trial NCT03512262?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 228 participants. The study started on 2018-05-03. Estimated completion is 2021-09-08.
What interventions are being tested in trial NCT03512262?
The interventions under investigation include: Placebo (DRUG), Abaloparatide (DRUG).
Who is sponsoring clinical trial NCT03512262?
This trial is sponsored by Radius Health, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03512262's enrollment target sits among peer trials
228 1309th of 2000 higher than 691 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05107908 · 228 participants · NA
Neuronal and Behavioral Effects of an Implicit Priming Approach to Improve Eating Behaviors in Obesity
- NCT05547698 · 228 participants · NA
A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation
- NCT05630963 · 228 participants
Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression
- NCT06073665 · 228 participants · Phase 4
Dosing of LT4 in Older Individuals
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI